LYRM4 and head and neck cancer: As shown in Fig. 10d, LYRM4 mRNA was significantly overexpressed in colon adenocarcinoma (COAD), head and neck cancer (HNSC), kidney renal papillary cell carcinoma (KIRP), LIHC, lung squamous cell carcinoma (LUSC), and prostate adenocarcinoma (PRAD; p < 0.001).